MedTrace Logo

The ATLANTA First in Man Study of the Catania Stent

NCT00799032 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2017-06-07

No results posted yet for this study

Summary

To evaluate the short-term and mid-term safety and efficacy of the Catania coronary stent for the treatment of up to two de novo lesions in native coronary arteries.

Conditions

Interventions

DEVICE

PCI

coronary stent implantation

Sponsors & Collaborators

  • CeloNova BioSciences, Inc.

    lead INDUSTRY

Principal Investigators

  • Corrado Tamburino, MD · Ferrarotto Hospital, University of Catania

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-08-31
Completion
2008-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00799032 on ClinicalTrials.gov